Protective Effects and Mechanisms of Vaccarin on Vascular Endothelial Dysfunction in Diabetic Angiopathy
Open Access
- 17 September 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (18) , 4587
Abstract
Cardiovascular complications are a major leading cause of mortality in patients suffering from type 2 diabetes mellitus (T2DM). Vascular endothelial dysfunction is a core pathophysiological event in the early stage of T2DM and eventually leads to cardiovascular disease. Vaccarin (VAC), an active flavonoid glycoside extracted from vaccariae semen, exhibits extensive biological activities including vascular endothelial cell protection effects. However, little is known about whether VAC is involved in endothelial dysfunction regulation under high glucose (HG) or hyperglycemia conditions. Here, in an in vivo study, we found that VAC attenuated increased blood glucose, increased glucose and insulin tolerance, relieved the disorder of lipid metabolism and oxidative stress, and improved endothelium-dependent vasorelaxation in STZ/HFD-induced T2DM mice. Furthermore, in cultured human microvascular endothelial cell-1 (HMEC-1) cells, we showed that pretreatment with VAC dose-dependently increased nitric oxide (NO) generation and the phosphorylation of eNOS under HG conditions. Mechanistically, VAC-treated HMEC-1 cells exhibited higher AMPK phosphorylation, which was attenuated by HG stimulation. Moreover, HG-triggered miRNA-34a upregulation was inhibited by VAC pretreatment, which is in accordance with pretreatment with AMPK inhibitor compound C (CC). In addition, both reactive oxygen species (ROS) scavenger N-acetyl-L-cysteine (NAC) and VAC abolished HG-evoked dephosphorylation of AMPK and eNOS, increased miRNA-34a expression, and decreased NO production. These results suggest that VAC impedes HG-induced endothelial dysfunction via inhibition of the ROS/AMPK/miRNA-34a/eNOS signaling cascade.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20170179)
- Fundamental Research Funds for the Central Universities (JUSRP11745)
- China Postdoctoral Science Foundation (2017M611688)
- Jiangsu Province Postdoctoral Science Foundation (1701062C)
- Jiangnan University Youth Fund 2018 (K2050205)
- Wuxi science and technology development fund 2018 (WX0302B010507180101 PB)
This publication has 42 references indexed in Scilit:
- In vivo metabolism study of vaccarin in rat using HPLC‐LTQ‐MSnBiomedical Chromatography, 2012
- Novel mechanisms of endothelial dysfunction in diabetesJournal of Cardiovascular Disease Research, 2010
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic SyndromeCell Metabolism, 2009
- NO/peroxynitrite dynamics of high glucose-exposed HUVECs: Chemiluminescent measurement and computational modelMicrovascular Research, 2009
- Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signallingCardiovascular Research, 2009
- Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?International Journal of Diabetes in Developing Countries, 2009
- Reactive oxygen species signaling in vascular smooth muscle cellsCardiovascular Research, 2006
- Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt siteJournal of Clinical Investigation, 2001
- The endothelium: a new target for therapyVascular Medicine, 2000
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979